These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 32349323)

  • 1. Hyaluronan-Metal Gold Nanoparticle Hybrids for Targeted Tumor Cell Therapy.
    Sanfilippo V; Caruso VCL; Cucci LM; Inturri R; Vaccaro S; Satriano C
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32349323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyaluronic acid co-functionalized gold nanoparticle complex for the targeted delivery of metformin in the treatment of liver cancer (HepG2 cells).
    Kumar CS; Raja MD; Sundar DS; Gover Antoniraj M; Ruckmani K
    Carbohydr Polym; 2015 Sep; 128():63-74. PubMed ID: 26005140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin.
    Gupta B; Poudel BK; Ruttala HB; Regmi S; Pathak S; Gautam M; Jin SG; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO
    Acta Biomater; 2018 Oct; 80():364-377. PubMed ID: 30201431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tunable CD44-specific cellular retargeting with hyaluronic acid nanoshells.
    Ebbesen MF; Olesen MT; Gjelstrup MC; Pakula MM; Larsen EK; Hansen IM; Hansen PL; Mollenhauer J; Malle BM; Howard KA
    Pharm Res; 2015 Apr; 32(4):1462-74. PubMed ID: 25361867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective Targeting and Restrictive Damage for Nonspecific Cells by Pulsed Laser-Activated Hyaluronan-Gold Nanoparticles.
    Rau LR; Tsao SW; Liaw JW; Tsai SW
    Biomacromolecules; 2016 Aug; 17(8):2514-21. PubMed ID: 27439142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyaluronan magnetic nanoparticle for mitoxantrone delivery toward CD44-positive cancer cells.
    Sargazi A; Shiri F; Keikha S; Majd MH
    Colloids Surf B Biointerfaces; 2018 Nov; 171():150-158. PubMed ID: 30025377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyaluronan-based nanocarriers with CD44-overexpressed cancer cell targeting.
    Song S; Qi H; Xu J; Guo P; Chen F; Li F; Yang X; Sheng N; Wu Y; Pan W
    Pharm Res; 2014 Nov; 31(11):2988-3005. PubMed ID: 24842660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifunctional tumor-targeting nanocarriers based on hyaluronic acid-mediated and pH-sensitive properties for efficient delivery of docetaxel.
    Song S; Chen F; Qi H; Li F; Xin T; Xu J; Ye T; Sheng N; Yang X; Pan W
    Pharm Res; 2014 Apr; 31(4):1032-45. PubMed ID: 24154802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dual-targeted hyaluronic acid-gold nanorod platform with triple-stimuli responsiveness for photodynamic/photothermal therapy of breast cancer.
    Xu W; Qian J; Hou G; Wang Y; Wang J; Sun T; Ji L; Suo A; Yao Y
    Acta Biomater; 2019 Jan; 83():400-413. PubMed ID: 30465921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyaluronic acid-fabricated nanogold delivery of the inhibitor of apoptosis protein-2 siRNAs inhibits benzo[a]pyrene-induced oncogenic properties of lung cancer A549 cells.
    Lin CM; Kao WC; Yeh CA; Chen HJ; Lin SZ; Hsieh HH; Sun WS; Chang CH; Hung HS
    Nanotechnology; 2015 Mar; 26(10):105101. PubMed ID: 25693888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of drug loaded nanoparticles for tumor targeting. Part 1: Synthesis, characterization, and biological evaluation in 2D cell cultures.
    El-Dakdouki MH; Puré E; Huang X
    Nanoscale; 2013 May; 5(9):3895-903. PubMed ID: 23529646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyaluronic acid-modified polyamidoamine dendrimer G5-entrapped gold nanoparticles delivering METase gene inhibits gastric tumor growth via targeting CD44+ gastric cancer cells.
    Li YF; Zhang HT; Xin L
    J Cancer Res Clin Oncol; 2018 Aug; 144(8):1463-1473. PubMed ID: 29858680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted and controlled drug delivery system loading artersunate for effective chemotherapy on CD44 overexpressing cancer cells.
    Tran TH; Nguyen TD; Van Nguyen H; Nguyen HT; Kim JO; Yong CS; Nguyen CN
    Arch Pharm Res; 2016 May; 39(5):687-94. PubMed ID: 27015824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and mechanistic insight into enhanced cytotoxic potential of hyaluronic acid conjugated nanoparticles in CD44 overexpressing cancer cells.
    Saneja A; Nayak D; Srinivas M; Kumar A; Khare V; Katoch A; Goswami A; Vishwakarma RA; Sawant SD; Gupta PN
    Eur J Pharm Sci; 2017 Jan; 97():79-91. PubMed ID: 27989859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-assembled nanoparticles based on hyaluronic acid-ceramide (HA-CE) and Pluronic® for tumor-targeted delivery of docetaxel.
    Cho HJ; Yoon HY; Koo H; Ko SH; Shim JS; Lee JH; Kim K; Kwon IC; Kim DD
    Biomaterials; 2011 Oct; 32(29):7181-90. PubMed ID: 21733572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyaluronic Acid-Coated Silica Nanoparticles for Targeted Delivery of Nitric Oxide to Cancer Cells.
    Grayton QE; Phan TT; Kussatz CC; Schoenfisch MH
    ACS Appl Bio Mater; 2024 Jun; 7(6):3796-3809. PubMed ID: 38776418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction-sensitive CD44 receptor-targeted hyaluronic acid derivative micelles for doxorubicin delivery.
    Yang Y; Zhao Y; Lan J; Kang Y; Zhang T; Ding Y; Zhang X; Lu L
    Int J Nanomedicine; 2018; 13():4361-4378. PubMed ID: 30100720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyaluronate coating enhances the delivery and biocompatibility of gold nanoparticles.
    Karakocak BB; Liang J; Biswas P; Ravi N
    Carbohydr Polym; 2018 Apr; 186():243-251. PubMed ID: 29455984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paclitaxel-loaded redox-sensitive nanoparticles based on hyaluronic acid-vitamin E succinate conjugates for improved lung cancer treatment.
    Song Y; Cai H; Yin T; Huo M; Ma P; Zhou J; Lai W
    Int J Nanomedicine; 2018; 13():1585-1600. PubMed ID: 29588586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual targeting mesoporous silica nanoparticles for inhibiting tumour cell invasion and metastasis.
    Li W; Guo Z; Zheng K; Ma K; Cui C; Wang L; Yuan Y; Tang Y
    Int J Pharm; 2017 Dec; 534(1-2):71-80. PubMed ID: 28958879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.